205 related articles for article (PubMed ID: 24204982)
1. Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6.
Gao J; Ha BH; Lou HJ; Morse EM; Zhang R; Calderwood DA; Turk BE; Boggon TJ
PLoS One; 2013; 8(10):e77818. PubMed ID: 24204982
[TBL] [Abstract][Full Text] [Related]
2. Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.
Ha BH; Davis MJ; Chen C; Lou HJ; Gao J; Zhang R; Krauthammer M; Halaban R; Schlessinger J; Turk BE; Boggon TJ
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16107-12. PubMed ID: 22988085
[TBL] [Abstract][Full Text] [Related]
3. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
Ha BH; Morse EM; Turk BE; Boggon TJ
J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
[TBL] [Abstract][Full Text] [Related]
4. Rho family GTPase signaling through type II p21-activated kinases.
Chetty AK; Ha BH; Boggon TJ
Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
[TBL] [Abstract][Full Text] [Related]
5. PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.
Morse EM; Sun X; Olberding JR; Ha BH; Boggon TJ; Calderwood DA
J Cell Sci; 2016 Jan; 129(2):380-93. PubMed ID: 26598554
[TBL] [Abstract][Full Text] [Related]
6. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
Sun X; Su VL; Calderwood DA
J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
[TBL] [Abstract][Full Text] [Related]
7. Recognition of physiological phosphorylation sites by p21-activated kinase 4.
Chetty AK; Sexton JA; Ha BH; Turk BE; Boggon TJ
J Struct Biol; 2020 Sep; 211(3):107553. PubMed ID: 32585314
[TBL] [Abstract][Full Text] [Related]
8. Functional deficits in PAK5, PAK6 and PAK5/PAK6 knockout mice.
Furnari MA; Jobes ML; Nekrasova T; Minden A; Wagner GC
PLoS One; 2013; 8(4):e61321. PubMed ID: 23593460
[TBL] [Abstract][Full Text] [Related]
9. Differential roles and regulation of the protein kinases PAK4, PAK5 and PAK6 in melanoma cells.
Murugesan G; Prescott AR; Toth R; Campbell DG; Wells CM; MacKintosh C
Biochem J; 2022 Aug; 479(16):1709-1725. PubMed ID: 35969127
[TBL] [Abstract][Full Text] [Related]
10. Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells.
Raja R; Sahasrabuddhe NA; Radhakrishnan A; Syed N; Solanki HS; Puttamallesh VN; Balaji SA; Nanjappa V; Datta KK; Babu N; Renuse S; Patil AH; Izumchenko E; Prasad TS; Chang X; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
Oncotarget; 2016 Sep; 7(38):61229-61245. PubMed ID: 27542207
[TBL] [Abstract][Full Text] [Related]
11. Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV.
Shepelev MV; Korobko IV
Biochemistry (Mosc); 2012 Jan; 77(1):26-32. PubMed ID: 22339630
[TBL] [Abstract][Full Text] [Related]
12. Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs.
Eswaran J; Lee WH; Debreczeni JE; Filippakopoulos P; Turnbull A; Fedorov O; Deacon SW; Peterson JR; Knapp S
Structure; 2007 Feb; 15(2):201-13. PubMed ID: 17292838
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion.
Nekrasova T; Jobes ML; Ting JH; Wagner GC; Minden A
Dev Biol; 2008 Oct; 322(1):95-108. PubMed ID: 18675265
[TBL] [Abstract][Full Text] [Related]
14. AR and ER interaction with a p21-activated kinase (PAK6).
Lee SR; Ramos SM; Ko A; Masiello D; Swanson KD; Lu ML; Balk SP
Mol Endocrinol; 2002 Jan; 16(1):85-99. PubMed ID: 11773441
[TBL] [Abstract][Full Text] [Related]
15. Identification of an autoinhibitory domain of p21-activated protein kinase 5.
Ching YP; Leong VY; Wong CM; Kung HF
J Biol Chem; 2003 Sep; 278(36):33621-4. PubMed ID: 12860998
[TBL] [Abstract][Full Text] [Related]
16. CDC42 binds PAK4 via an extended GTPase-effector interface.
Ha BH; Boggon TJ
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):531-536. PubMed ID: 29295922
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.
Pandey A; Dan I; Kristiansen TZ; Watanabe NM; Voldby J; Kajikawa E; Khosravi-Far R; Blagoev B; Mann M
Oncogene; 2002 May; 21(24):3939-48. PubMed ID: 12032833
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.
Murray BW; Guo C; Piraino J; Westwick JK; Zhang C; Lamerdin J; Dagostino E; Knighton D; Loi CM; Zager M; Kraynov E; Popoff I; Christensen JG; Martinez R; Kephart SE; Marakovits J; Karlicek S; Bergqvist S; Smeal T
Proc Natl Acad Sci U S A; 2010 May; 107(20):9446-51. PubMed ID: 20439741
[TBL] [Abstract][Full Text] [Related]
19. Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase.
Kaur R; Liu X; Gjoerup O; Zhang A; Yuan X; Balk SP; Schneider MC; Lu ML
J Biol Chem; 2005 Feb; 280(5):3323-30. PubMed ID: 15550393
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6.
Yang F; Li X; Sharma M; Zarnegar M; Lim B; Sun Z
J Biol Chem; 2001 May; 276(18):15345-53. PubMed ID: 11278661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
